Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
A Real Patient Journey (Anonymized) The following is a composite based on common patient patterns, with all identifying details changed
Retatrutide does act on the GLP-1 receptor, but it is not a GLP-1-only medication like semaglutide
De novo GLP-1RAs Design Our de novo GLP-1 RAs design pipeline consists of two primary stages: conserved sites analysis and ProteinMPNN de novo sequences design
Compounded medications contain the same active pharmaceutical ingredient as the FDA-approved brand-name drugs (Wegovy, Ozempic, Zepbound, Mounjaro), but the compounded versions themselves are not FDA-approved as finished products and have not been individually evaluated by the FDA for safety, efficacy, or quality
Whichever medication you are taking, your healthcare provider will likely have you start with a low dose, before slowly increasing your dose over a period of weeks to months until you reach an effective maintenance dose
